Diffuse Gastric Adenocarcinoma
1 clinical trials · Condition
◉ Watch Diffuse Gastric Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Akt Inhibitor MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction Cancer (NCT01260701) | National Cancer Institute (NCI) | 2011-01-01 |
Track Diffuse Gastric Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.